ARK Genomic Revolution ETF · $2.2B$6,586
ARKGARKG vsIBBIBBiShares Biotechnology ETF · $11.2B$13,634
$10,000 five years ago, dividends reinvested · they hold 11.2% in common
ARKGMeasureIBB
Returns · dividends reinvested
+70.9%Year to dateJan 1 → Nov 3+27.8%
+59.0%1 yearTotal return+35.5%
+30.6%3 years · per year$10,000 became $22,262 · $19,307+24.5%
−8.0%5 years · per year$10,000 became $6,586 · $13,634+6.4%
Cost and income
0.75%Expense ratio$75 · $44 a year on $10k · lower is better0.44%
0.00%Trailing 12-mo yield$0 · $16 a year on $10k0.16%
Risk · past year
−27.5%Worst dropSmaller is better−9.6%
45.8%VolatilityLower is calmer22.7%
ARKGIBB Winner of the row, in its colourEach row: the bigger of the two fills its side
3–5IBB wins
End-of-day Nov 3, 2026 · returns include dividends · 3Y and 5Y figures are per-year returns